Disclosures for "Resilience and Recovery: Exploring the Spectrum of Physical Wellbeing in Ischemic and Hemorrhagic Stroke Survivors Through Diverse Therapy Experiences"
-
Ms. Constantinescu has nothing to disclose.
-
Ms. Kitagawa has nothing to disclose.
-
Dr. Choksi has nothing to disclose.
-
Miss DeLuca has received personal compensation for serving as an employee of Wilson Center Maternal Health Initiative. Miss DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Khushi Baby.
-
Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Rosand has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for National Football League. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities.
-
Dr. Sansing has nothing to disclose.
-
Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Egger has nothing to disclose.
-
The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
-
Dr. Yechoor has nothing to disclose.
-
Dr. Forman has nothing to disclose.